Dana C Miskulin

Summary

Affiliation: Tufts Medical Center
Country: USA

Publications

  1. pmc Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study
    Dana C Miskulin
    Tufts Medical Center, Boston, MA Electronic address
    Am J Kidney Dis 63:214-26. 2014
  2. pmc Trends in anemia management in US hemodialysis patients 2004-2010
    Dana C Miskulin
    Division of Nephrology, Tufts University School of Medicine, Boston, MA, USA
    BMC Nephrol 14:264. 2013
  3. pmc Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study
    L Ebony Boulware
    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, 2024 E, Monument Street, Baltimore, MD 21205, USA
    BMC Nephrol 13:167. 2012
  4. pmc Computerized decision support for EPO dosing in hemodialysis patients
    Dana C Miskulin
    Tufts Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 54:1081-8. 2009
  5. pmc Key comorbid conditions that are predictive of survival among hemodialysis patients
    Dana Miskulin
    Division of Nephrology, Tufts Medical Center, 800 Washington Street, Box 391, Boston, MA 02111, USA
    Clin J Am Soc Nephrol 4:1818-26. 2009
  6. ncbi request reprint Comorbidity and its change predict survival in incident dialysis patients
    Dana C Miskulin
    Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 41:149-61. 2003
  7. ncbi request reprint Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments
    Dana C Miskulin
    Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Nephrol Dial Transplant 19:413-20. 2004
  8. ncbi request reprint Reducing versus discontinuing erythropoietin at high hemoglobin levels
    Daniel E Weiner
    Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    J Am Soc Nephrol 18:3184-91. 2007
  9. pmc Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patients
    Jose A Calvo
    Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 5:1621-7. 2010
  10. pmc Temporal trends in health-related quality of life among hemodialysis patients in the United States
    Ezra Gabbay
    William B Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Clin J Am Soc Nephrol 5:261-7. 2010

Detail Information

Publications16

  1. pmc Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study
    Dana C Miskulin
    Tufts Medical Center, Boston, MA Electronic address
    Am J Kidney Dis 63:214-26. 2014
    ..We hypothesized that increased TKV would be a source of morbidity and diminished quality of life that would be worse in patients with more advanced disease...
  2. pmc Trends in anemia management in US hemodialysis patients 2004-2010
    Dana C Miskulin
    Division of Nephrology, Tufts University School of Medicine, Boston, MA, USA
    BMC Nephrol 14:264. 2013
    ..There have been major changes in the management of anemia in US hemodialysis patients in recent years. We sought to determine the influence of clinical trial results, safety regulations, and changes in reimbursement policy on practice...
  3. pmc Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study
    L Ebony Boulware
    Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, 2024 E, Monument Street, Baltimore, MD 21205, USA
    BMC Nephrol 13:167. 2012
    ..Evidence is lacking to inform providers' and patients' decisions about many common treatment strategies for patients with end stage renal disease (ESRD)...
  4. pmc Computerized decision support for EPO dosing in hemodialysis patients
    Dana C Miskulin
    Tufts Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 54:1081-8. 2009
    ..The present study explored the hypothesis that computerized dosing of intravenous erythropoietin (EPO) would increase the percentage of hemoglobin (Hb) values within the target range and reduce staff time spent on anemia management...
  5. pmc Key comorbid conditions that are predictive of survival among hemodialysis patients
    Dana Miskulin
    Division of Nephrology, Tufts Medical Center, 800 Washington Street, Box 391, Boston, MA 02111, USA
    Clin J Am Soc Nephrol 4:1818-26. 2009
    ..We sought to determine which conditions are most prognostic and whether comorbidity continues to contribute to a survival model once laboratory and clinical parameters have been accounted for...
  6. ncbi request reprint Comorbidity and its change predict survival in incident dialysis patients
    Dana C Miskulin
    Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 41:149-61. 2003
    ..Longitudinal change in the comorbid illness burden of incident dialysis patients has not been measured. Comorbidity severity and its change may serve as important prognostic markers of survival, independent of other case-mix factors...
  7. ncbi request reprint Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments
    Dana C Miskulin
    Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
    Nephrol Dial Transplant 19:413-20. 2004
    ..We compare the discriminatory accuracy of 1 year mortality predictions derived from four comorbidity instruments in a large representative US dialysis population...
  8. ncbi request reprint Reducing versus discontinuing erythropoietin at high hemoglobin levels
    Daniel E Weiner
    Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
    J Am Soc Nephrol 18:3184-91. 2007
    ....
  9. pmc Nadir hemoglobin levels after discontinuation of epoetin in hemodialysis patients
    Jose A Calvo
    Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 5:1621-7. 2010
    ..In hemodialysis patients, both hemoglobin variability and targeting normalization of hemoglobin may have adverse consequences. There are few data on epoetin management in patients achieving high hemoglobin levels...
  10. pmc Temporal trends in health-related quality of life among hemodialysis patients in the United States
    Ezra Gabbay
    William B Schwartz Division of Nephrology, Tufts Medical Center, Boston, Massachusetts 02111, USA
    Clin J Am Soc Nephrol 5:261-7. 2010
    ..Health-related quality of life (HRQOL) is a measure of the well being of hemodialysis patients and an independent prognostic predictor. Our aim was to determine whether HRQOL among hemodialysis patients has changed over time...
  11. pmc Variation in fistula use across dialysis facilities: is it explained by case-mix?
    Navdeep Tangri
    Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA
    Clin J Am Soc Nephrol 5:307-13. 2010
    ..This study aimed to determine the magnitude of the variability in AVF usage across dialysis facilities and the extent to which patient case-mix explains it...
  12. ncbi request reprint Demographics and trends in overweight and obesity in patients at time of kidney transplantation
    Allon N Friedman
    Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, USA
    Am J Kidney Dis 41:480-7. 2003
    ..The authors describe the prevalence, demographics, and trends in overweight and obesity at the time of kidney transplantation...
  13. pmc Updated comorbidity assessments and outcomes in prevalent hemodialysis patients
    Tara I Chang
    Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA
    Hemodial Int 14:478-85. 2010
    ..Updated assessments of comorbidity significantly strengthen the ability to predict death in patients on hemodialysis. Future studies in dialysis should invest the necessary resources to include repeated assessments of comorbidity...
  14. ncbi request reprint Comorbidity and other factors associated with modality selection in incident dialysis patients: the CHOICE Study. Choices for Healthy Outcomes in Caring for End-Stage Renal Disease
    Dana C Miskulin
    Division of Nephrology, New England Medical Center, Boston, MA 02111, USA
    Am J Kidney Dis 39:324-36. 2002
    ..Adjustment for case-mix differences in patients treated with PD versus HD is essential to the assessment of the independent effect of the dialysis modality on outcomes...
  15. doi request reprint Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry
    Navdeep Tangri
    Division of Nephrology, Tufts Medical Center, Boston MA 02111, USA
    Am J Kidney Dis 57:415-21. 2011
    ..However, whether achievement of these targets improves survival is unknown...
  16. ncbi request reprint Making an earlier diagnosis of ADPKD: implications for the treatment of hypertension
    Ron Perrone
    Tufts New England Medical Center, Boston, MA, USA
    Nephrol News Issues 20:32, 35-6. 2006